| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/17/2008 | US7387998 STQ peptides |
| 06/17/2008 | US7387997 analogs of alpha -Conotoxin MII that are selective for alpha 6-containing nicotinic acetylcholine receptors; useful for the treatment of disorders involving ion channels, ligand-gated channels, or receptors; inhibiting pain |
| 06/17/2008 | US7387879 Diagnosis of tauopathies |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 06/17/2008 | CA2255062C Process of purification of cyclosporin |
| 06/17/2008 | CA2186497C Factor xa inhibitors |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/17/2008 | CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification |
| 06/12/2008 | WO2008069917A2 Novel cyclic peptides |
| 06/12/2008 | WO2008008348A3 Method and compositions for treating stroke with fever |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | US20080139479 Intelligent drug carrier capable of selective delivery; reduced side effects; isolated, labeled peptide of amino acid sequence 7; antibodies; kits |
| 06/12/2008 | US20080139478 IL-10 Related Peptides For Wound Healing |
| 06/12/2008 | US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof |
| 06/12/2008 | US20080139401 Isolating biological modulators from biodiverse gene fragment libraries |
| 06/12/2008 | US20080138909 Mass Spectrometry of Arginine-Containing Peptides |
| 06/12/2008 | US20080138847 Bcl-2 family member and BH-3 only proteins for use in development of peptidomimetics |
| 06/12/2008 | US20080138356 Pili from Mycobacterium Tuberculosis |
| 06/12/2008 | US20080138278 Conjugates of rgd peptides and porphyrin or (bacterio) chlorohyll photosynthesizers and their uses |
| 06/12/2008 | CA2671410A1 Peptide and treatment for hiv-1 infection |
| 06/12/2008 | CA2667574A1 Compositions and methods for binding sphingosine-1-phosphate |
| 06/11/2008 | EP1930427A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 06/11/2008 | EP1930406A1 Brain-migrating cell and use thereof |
| 06/11/2008 | EP1929869A1 Composition for controlling common scab of agricultural crop containing surfactin |
| 06/11/2008 | EP1929022A2 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 06/11/2008 | EP1928896A2 Anchoring disruption molecules |
| 06/11/2008 | EP1928895A2 Enhancer elements |
| 06/11/2008 | EP1928397A1 Method for enhancing effects of colorants and conditioners |
| 06/11/2008 | CN101198346A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198318A Antibiotique composition |
| 06/11/2008 | CN101195654A Solid phase synthesis technique for melanotan-II |
| 06/11/2008 | CN101195653A solid-liquid synthesizing method for leuprorelin |
| 06/11/2008 | CN100393881C Structural body containing polyhydroxy chain alkyl ester and its production method |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/10/2008 | US7385027 unlike calpastatin, the peptides of the invention do not target an active cysteine of calpain; protecting neurons against ultraviolet radiation induced cell death |
| 06/10/2008 | US7385025 Comprising biologically active alpha-melanocyte stimulating hormone, gamma-melanocyte stimulating hormone, or bombesin sequence wherein residue comprising nitrogen atom and sulfur atom each available for complexation to metal ion is inserted between two and three position to c-terminus side of n position |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | CA2423481C Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2248348C Process for the deacylation of cyclic lipopeptides |
| 06/10/2008 | CA2229028C Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/05/2008 | WO2008066070A1 Dipeptidyl peptidase-iv inhibitor |
| 06/05/2008 | WO2008064907A1 Polypeptides having modulatory effects on cells |
| 06/05/2008 | WO2008064401A1 Improved peptide composition |
| 06/05/2008 | WO2008013454B1 Immunogenic compounds and protein mimics |
| 06/05/2008 | WO2008011168A3 Glycosylated peptide antagonists of the bradykinin b1 receptor |
| 06/05/2008 | US20080132454 bioavailable ACE-inhibiting peptides that are absorbed intact; protein hydrolysate; hydrolyzing the casein fraction using a protease, subtilisin; foods, beverages |
| 06/05/2008 | US20080132453 amino acid sequence: One example is Nal-Tyr-cyclo(D-Cys-D-Trp-Lys-D-Cys)-Abu-Nal-NH2; lung cancer, glioma, anorexia, hypothyroidism; various D-amino acid-substituted and constrained amino acid-substituted cyclo somatostatin analogs that function as potent mu opioid receptor antagonists |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080131933 Process of Producing a Plastid-Targeted Protein in Plant Cells |
| 06/05/2008 | US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy |
| 06/05/2008 | US20080131368 Technetium-base radiopharmaceuticals; biocompatability; kits |
| 06/05/2008 | CA2671060A1 Polypeptides having modulatory effects on cells |
| 06/04/2008 | EP1927597A1 Antibacterial peptides |
| 06/04/2008 | EP1927364A1 Polypeptides having modulatory effects on cells |
| 06/04/2008 | EP1794180B1 Peptide cyclisation |
| 06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
| 06/04/2008 | CN101190942A Compound with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190941A Polypeptide with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190940A Polypeptide with target antithrombotic activity and its preparation method and application |
| 06/04/2008 | CN101190939A Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN100391968C Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381706 Gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 06/03/2008 | US7381705 Inhibitors of hepatitis C virus |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381701 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | CA2195528C Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 05/29/2008 | WO2008063291A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/29/2008 | US20080125374 Gd3-mimetic peptides |
| 05/29/2008 | US20080125372 Biologically Active Peptide Vapeehptllteaplnpk Derivatives |
| 05/29/2008 | US20080125367 Agents for treatment of HCV and methods of use |
| 05/29/2008 | US20080125359 Antimicrobial peptides and methods of identifying the same |
| 05/29/2008 | US20080125355 Endogenous Peptide and Active Subfragments Thereof |
| 05/29/2008 | US20080125351 Forming water-in-oil emulsion from aqueous phase (water soluble polypeptide and sugar) and oil phase comprising glycolic acid-lactic acid copolymer and solvent, adding silicone oil, hardening, drying; optimizing the silicone oil to polymer ratio to improve bioavailability of peptide drug |
| 05/29/2008 | US20080124808 Using three dimensional hydrolase structure as tool in designing modulators of enzyme activity; rational drug design |
| 05/29/2008 | US20080124807 Protein tagging reagents |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124354 Her-2 protein fragments, recombinant peptides comprising same, nucleotide molecules encoding same, recombinant vaccine vectors and immunogenic compositions comprising same, and methods for inducing immune response and treating cancer, comprising same |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | CA2665839A1 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/28/2008 | EP1925625A2 Method for screening modulators of mitochondrial functionning and new modulators obtained |
| 05/28/2008 | EP1924595A2 Novel peptides and uses thereof |
| 05/28/2008 | EP1549333A4 Compstatin analogs with improved activity |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | EP1012741B1 Methods for designing small molecule mimetics of erythropoietin |
| 05/28/2008 | CN101189253A Antiinfective lipopeptides |
| 05/28/2008 | CN101189252A Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| 05/28/2008 | CN101186635A Application of M3 type receptor protein polypeptide resisting antibody measurement in Sjogren syndrome diagnosis |